UNPKG

skills-ws

Version:

87 agent skills for AI coding assistants — marketing, growth, web3, dev, design & operations. Built for OpenClaw, Claude Code, Cursor, and Codex.

55 lines (43 loc) • 5.37 kB
## Contents - 10. Quick Decision Matrix - "Where should I incorporate in the EU?" — read this first - Total Employer Cost Example (€100K gross salary) ## 10. Quick Decision Matrix ### "Where should I incorporate in the EU?" — read this first > **Do NOT pick a jurisdiction off a headline-rate table.** Choosing an entity location is high-stakes structuring. A low statutory rate is routinely neutralized — or made worse — by **permanent establishment (PE)**, **place-of-effective-management**, **CFC**, **Pillar Two (15% floor for groups ≥ €750M)**, **substance/anti-abuse (GAAR, EU Code of Conduct)**, **transfer pricing**, **exit tax**, **investor/treaty constraints**, **VAT registration obligations where customers are**, and **where you actually employ people**. Tax authorities tax where value is created and managed, not where you registered. **A wrong structure can create double taxation, denied treaty benefits, back-tax, penalties and personal-liability exposure. This is a workflow to scope a conversation with a qualified cross-border tax adviser — not a recommendation.** **Decision workflow — answer these before any jurisdiction is even shortlisted:** 1. **Where is management/board actually located?** (Drives place-of-effective-management → corporate tax residence, regardless of registration.) 2. **Where are the employees / the real activity?** (Creates PE and payroll/social-security obligations there; "letterbox" companies are attacked.) 3. **Where are the customers?** (Drives VAT registration/OSS and, for digital, destination VAT — see §2.) 4. **Who owns the IP, and where was the R&D done?** (Nexus rules cap IP-box benefits to self-performed R&D; misalignment triggers TP adjustments.) 5. **Who are the investors / will you raise VC or list?** (VCs often require Delaware/known holdco forms; treaty access depends on shareholder residence; some reliefs require individual ownership.) 6. **Can you build real substance** (local directors, staff, premises, genuine costs) proportionate to the benefit claimed? If not, the benefit is fragile under GAAR. 7. **Is the group ≥ €750M revenue** (Pillar Two) or are there **CFC** low-tax subsidiaries? If yes, low-rate jurisdictions deliver little net benefit. 8. **PE / exit-tax exposure** from moving an existing business or assets cross-border? 9. **Have you priced full cost of ownership** — payroll burden (§3), filing/audit/e-invoicing compliance (§4, §6, §9), and professional fees — not just the CIT rate? 10. **Get local counsel + a cross-border tax adviser** to validate before incorporating, and re-confirm after any annual finance-law change. **Factor → jurisdictions commonly *evaluated* (then validated against the workflow, never assumed):** | If the dominant factor is… | Jurisdictions often evaluated | The catch to test | |----------------------------|-------------------------------|-------------------| | Lowest headline CIT | Hungary (9%), Bulgaria (10%), Ireland (12.5%) | Local business taxes (HU HIPA), limited IP/holding fit, Pillar Two for large groups | | IP-heavy business | Ireland (KDB 10%), Netherlands (Innovation Box 9%), Cyprus/Belgium IP boxes | Nexus rule caps benefit to self-performed R&D; substance + DEMPE analysis required | | Holding company | Netherlands, Luxembourg, Ireland | Participation-exemption conditions; substance; anti-conduit (PPT/GAAR); directive limits | | Startup with R&D | France (CIR/CII), Ireland (R&D credit/KEEP), Germany (Forschungszulage), Poland (R&D relief/IP Box) | Cash vs. credit timing; staff-relief vs. CIT-relief; state-aid caps; eligibility windows | | E-commerce / digital | Ireland, Estonia (0% retained), Cyprus | Destination VAT/OSS regardless of seat; PE where staff sit | | Lowest payroll cost | Eastern EU (Bulgaria, Romania, Hungary) | Talent availability; employee-side burden; still creates PE where staff work | | Substance + prestige / English-language | Netherlands, Ireland, Luxembourg | Higher cost base; still must meet substance to keep benefits | ### Total Employer Cost Example (€100K gross salary) | Country | Employer Social Contributions | Total Employer Cost | Employee Net (approx.) | |---------|------------------------------|--------------------|-----------------------| | France | ~€43,000 | ~€143,000 | ~€62,000 | | Belgium | ~€25,000 | ~€125,000 | ~€58,000 | | Germany | ~€21,000 | ~€121,000 | ~€60,000 | | Spain | ~€30,000 | ~€130,000 | ~€65,000 | | Italy | ~€30,000 | ~€130,000 | ~€60,000 | | Netherlands | ~€18,000 | ~€118,000 | ~€63,000 | | Ireland | ~€11,000 | ~€111,000 | ~€67,000 | | Luxembourg | ~€14,000 | ~€114,000 | ~€72,000 | | Estonia | ~€34,000 | ~€134,000 | ~€75,000 | | Denmark | ~€2,000 | ~€102,000 | ~€55,000 (high income tax) | *Rough order-of-magnitude only, illustrating relative burden — NOT a quote.* A €100K salary sits **above the contribution ceiling in several countries** (Germany, France-capped lines, Luxembourg, Netherlands, Spain), so employer cost does **not** scale linearly: low-salary roles look very different. Recompute with the **current-year ceilings in §3**, the applicable collective agreement, accident-insurance risk class, and family/marital status. Employee-net also depends on local income-tax bands and personal circumstances. ---